ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals Inc (AMLX)

17,79
0,35
(2,01%)
Geschlossen 27 Juni 10:00PM
17,79
0,00
(0,00%)
Nach Börsenschluss: 1:46AM

Amylyx Pharmaceuticals Inc (AMLX) Insidergeschäfte

-
Filtern nach:
Datum Name des Inhabers Gehandelte Aktien Wertspanne ($) Transaktionstyp Preisspanne ($) Aktien am Meldungsende % Veränderung
2026-05-21Ms. Karen Mindy FirestoneIndependent Director3,80k51,34kKauf13,5166,90k6,02%
2026-03-02Mr. James M. FratesCFO-7,91k114,85kVerkauf14,52210,02k-3,63%
2026-03-02Ms. Gina M. MazzarielloChief Legal Officer & General Counsel-6,84k99,38kVerkauf14,5259,04k-10,39%
2026-03-02Dr. Camille L. BedrosianChief Medical Officer-6,46k94,21kVerkauf14,5888,81k-6,78%
2026-03-02Mr. Joshua B. CohenCo-Founder, Co-CEO & Director-29,28k424,12kVerkauf14,483,11M-0,93%
2026-03-02Mr. Justin B. KleeCo-CEO & Director-29,28k423,76kVerkauf14,473,07M-0,95%
2026-02-23Ms. Gina M. MazzarielloChief Legal Officer & General Counsel-3,42k48,35kVerkauf14,1440,76k-7,74%
2026-02-02Mr. Justin B. KleeCo-CEO & Director-15,50k227,62kVerkauf14,693,10M-0,50%
2026-02-02Ms. Gina M. MazzarielloChief Legal Officer & General Counsel-3,45k50,52kVerkauf14,6543,09k-7,41%
2026-02-02Mr. Joshua B. CohenCo-Founder, Co-CEO & Director-15,50k227,59kVerkauf14,683,10M-0,50%
2026-02-02Mr. James M. FratesCFO-3,56k52,10kVerkauf14,65200,83k-1,74%
2026-01-15Mr. Justin B. KleeCo-CEO & Director61,81k467,92kDerivative Exercise and Retained Stock7,573,08M2,05%
2026-01-15Mr. Justin B. KleeCo-CEO & Director-138,19k831,49kDerivative Exercise and Sale7,57 - 13,893,08M-
2026-01-15Mr. Joshua B. CohenCo-Founder, Co-CEO & Director61,83k468,08kDerivative Exercise and Retained Stock7,573,08M2,05%
2026-01-15Mr. Joshua B. CohenCo-Founder, Co-CEO & Director-138,17k832,17kDerivative Exercise and Sale7,57 - 13,833,08M-
2026-01-12Dr. George Mclean MilneIndependent Chairman of the Board-17,78k0,00Other Disposition-812,88k-2,14%
2026-01-06Mr. Justin B. KleeCo-CEO & Director-7,72k85,59kVerkauf11,093,02M-0,26%
2026-01-06Mr. Joshua B. CohenCo-Founder, Co-CEO & Director-7,72k85,60kVerkauf11,093,02M-0,26%
2026-01-06Mr. James M. FratesCFO-3,33k36,95kVerkauf11,11194,38k-1,68%
2025-12-23Ms. Karen Mindy FirestoneIndependent Director8,10k100,85kKauf12,4563,10k14,73%
2025-12-01Dr. Camille L. BedrosianChief Medical Officer-6,58k94,42kVerkauf14,3578,17k-7,76%
2025-09-30Dr. Camille L. BedrosianChief Medical Officer-12,04k175,52kVerkauf14,5870,17k-14,65%
2025-09-30Ms. Gina M. MazzarielloChief Legal Officer & General Counsel-8,83k128,67kVerkauf14,5837,37k-19,11%
2025-09-30Mr. Joshua B. CohenCo-Founder, Co-CEO & Director-29,93k429,47kVerkauf14,34 - 15,003,01M-0,99%
2025-09-30Mr. James M. FratesCFO-10,56k154,65kVerkauf14,65189,79k-5,27%
2025-09-30Mr. Justin B. KleeCo-CEO & Director-29,98k430,95kVerkauf14,37 - 15,013,01M-0,99%
2025-08-12Ms. Gina M. MazzarielloChief Legal Officer & General Counsel-30,00k246,15kAutomatic Disposition8,07 - 8,3418,81k-61,46%